{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:23:09Z","timestamp":1777310589575,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"vor","delay-in-days":931,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jjcc.2010.09.003","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T04:28:17Z","timestamp":1289363297000},"page":"77-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (\u226565 years old)"],"prefix":"10.1016","volume":"57","author":[{"given":"Hiroshige","family":"Itakura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokata","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsaku","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seibu","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitsugu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2010.09.003_bib0005","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1253\/circj.66.1087","article-title":"Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia","volume":"66","author":"Matsuzaki","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"68","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0030","unstructured":"Good Post-marketing Surveillance Practice regulations, version 10. Japanese Ministry of Health and Welfare; March 10, 1997."},{"key":"10.1016\/j.jjcc.2010.09.003_bib0035","first-page":"1","article-title":"Guidelines for the treatment of hyperlipidemia","volume":"25","year":"1997","journal-title":"J Jpn Atheroscler Soc"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0040","series-title":"Practice guide for obesity","year":"1993"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1253\/circj.67.287","article-title":"Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients","volume":"67","author":"Matsuzawa","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0050","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2008.08.039","article-title":"Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients","volume":"52","author":"Mills","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2006.06.003","article-title":"The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials","volume":"117","author":"Holdaas","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0060","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1600-6143.2004.00445.x","article-title":"Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study","volume":"4","author":"Jardine","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0065","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00000441-200605000-00007","article-title":"Effect of lipid levels and lipid-lowering therapy on restenosis after coronary artery stenting","volume":"331","author":"Lerakis","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijcard.2003.11.031","article-title":"Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease","volume":"98","author":"Lemos","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(99)00062-3","article-title":"The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment","volume":"144","author":"Riegger","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9149(97)00346-9","article-title":"Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])","volume":"80","author":"Herd","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0090","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00019501-199809090-00005","article-title":"Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin","volume":"9","author":"Lye","year":"1998","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0100","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2005.06.030","article-title":"Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus \u226465 years of age","volume":"96","author":"Bruckert","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0105","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.97.15.1453","article-title":"Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)","volume":"97","author":"Pedersen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0110","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.97.15.1446","article-title":"Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial","volume":"97","author":"Sacks","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1536\/jhj.45.969","article-title":"Effects of statins on circulating oxidized low-density lipoprotein in patients with hypercholesterolemia","volume":"45","author":"Inami","year":"2004","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0021-9150(96)05972-2","article-title":"Reduced susceptibility of low density lipoprotein to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL","volume":"128","author":"Hussein","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0125","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.jacc.2005.06.084","article-title":"Effects of fluvastatin on the carotid arterial media as assessed by integrated backscatter ultrasound compared with pulse-wave velocity","volume":"46","author":"Yokoyama","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00005344-199805000-00017","article-title":"Direct effects of statins on the vascular wall","volume":"31","author":"Corsini","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/hc2901.093188","article-title":"Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease","volume":"104","author":"Schartl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01213011-200505000-00008","article-title":"Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the \u2212786T>C polymorphism","volume":"15","author":"Abe","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/187152208784587881","article-title":"Statin biology beyond cholesterol lowering: hepatic statins vs. vascular statins","volume":"8","author":"Morishita","year":"2008","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0150","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2007.12.049","article-title":"Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers","volume":"51","author":"Yasue","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3122\/jabfm.2007.04.060187","article-title":"Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir","volume":"20","author":"Schmidt","year":"2007","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0160","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4065\/83.11.1296","article-title":"Fluvastatin, rhabdomyolysis, and myotoxicity","volume":"83","author":"Murinson","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0165","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/ndt\/gfq157","article-title":"Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient","volume":"25","author":"Basic-Jukic","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0025-6196(11)60897-5","article-title":"Toward \u201cpain-free\u201d statin prescribing: clinical algorithm for diagnosis and management of myalgia","volume":"83","author":"Jacobson","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jjcc.2010.09.003_bib0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clinthera.2007.02.008","article-title":"Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy","volume":"29","author":"Silva","year":"2007","journal-title":"Clin Ther"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508710001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508710001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:48:58Z","timestamp":1760273338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508710001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0914508710001796"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.09.003","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (\u226565 years old)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}